Paras Healthcare IPO Opens Oct 21 at ₹660-693 Per Share; Proceeds to Repay Borrowings

• Paras Healthcare has set its IPO price band at ₹660-693 per share for its ₹1,450 crore issue, opening October 21.
• The offering combines a fresh issue of ₹500 crore and an offer for sale worth ₹950 crore, with fresh proceeds primarily earmarked for debt repayment.
• Paras Healthcare operates multi-specialty hospitals primarily in North India, competing in a sector that has seen strong post-pandemic patient volumes and premium pricing power.

Paras Healthcare's IPO enters a market that has delivered mixed results for healthcare listing candidates over the past 18 months. The hospital sector broadly has performed well operationally — patient volumes recovered to above pre-pandemic levels, and ARPOB (average revenue per occupied bed) has been on a sustained upward trajectory as hospitals successfully introduced premium service pricing. Paras Healthcare's North India focus differentiates it from larger operators like Apollo, Fortis, and Max Healthcare, which have broader pan-India networks and larger revenue bases that institutional investors tend to prefer.

The primary use of fresh issue proceeds for debt repayment is a common structure for healthcare IPOs but is sometimes viewed as less growth-accretive than proceeds dedicated to capacity expansion. Investors will want to understand Paras's total bed capacity, current occupancy rates, and whether the ₹1,450 crore raise at the top band implies a valuation that is reasonable relative to EV/EBITDA multiples for comparable listed hospital chains. At ₹693 per share, the implied market capitalisation positions the company for mid-cap index inclusion if post-listing price discovery is favourable.

The listing timing — coinciding with the Jio Platforms IPO — creates a competitive capital allocation context, as institutional investors may need to prioritise between a large telecom/tech listing and a mid-size healthcare operator. Paras's GMP data and QIB subscription rate on day 1 will be the key real-time indicators of institutional appetite. The healthcare sector's structural tailwinds (India's under-hospitalised population, growing medical tourism, rising health insurance penetration) remain supportive, but single-hospital-chain IPOs without national scale require investors to have confidence in management execution and regional market defensibility.